Catalyst Biosciences (CBIO) Reports Q2 Loss of $0.42/Share

Catalyst Biosciences (NASDAQ: CBIO) reported Q2 EPS of ($0.42), versus ($4.60) reported last year.

For earnings history and earnings-related data on Catalyst Biosciences (CBIO) click here.

You May Also Be Interested In

• onsemi downgraded by TD Cowen after Synaptics deal clouds growth story
• Darden Restaurants (DRI) PT Raised to $240 at UBS as Stock Remains a 'Quality Compounder'
• Benchmark Reiterates Buy Rating on Kura Sushi USA Inc. (KRUS) Ahead of Q3 Print